Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boswellia Window Trial for Breast Primary Tumors
NCT03149081Phase 1Completed
- Sponsor
- Medical University of South Carolina
- Start
- Aug 2017
- Primary completion
- Apr 2024
- Modality
- NHE (Natural Herbal Extract)
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of boswellia serrata in breast cancer, sponsored by Medical University of South Carolina. Primary endpoint: Change in tumor proliferation rate up to 56 days. Started Aug 2017; status: completed.
02
Drugs
boswellia serrata
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03149081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03149081.